http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17350553

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 1694
issn 0140-6736
issueIdentifier 9625
pageRange 1685-1694
publicationName Lancet (London, England)
startingPage 1685
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2d9cb39c3202a8c247044547e7f978aa
bibliographicCitation Muers MF, Stephens RJ, Fisher P, Darlison L, Higgs CM, Lowry E, Nicholson AG, O'Brien M, Peake M, Rudd R, Snee M, Steele J, Girling DJ, Nankivell M, Pugh C, Parmar MK; MS01 Trial Management Group. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial. Lancet. 2008 May 17;371(9625):1685–94. PMID: 18486741; PMCID: PMC2431123.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b20da92955000ed08c07324ee198811d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97998ccd6801c6783db2f756fb8af0bb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_add2a07dde9ce1a196c251fd3ed4d506
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9f2883682eee2cb5fb844994c5137ff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d12c9749cd9cc3b9ccfcb36fc68344a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26df9a2448f61b705e816b6d34630a28
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_624a1489e9446dda4c5e484d2114c8ec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a42b6ec23f03a6800a0a07bac2ed6ec0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7de2ae649523e7d7cc08082690e6843c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4aec6d957311b10da212cd0edd800f49
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a33b19fcd9ec8994d9a593141489c001
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7460a51d30d4483d7809cc416ddeca6a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d48a6222ea3e15e03f609f3f2185003b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9300abf08e3519b4908658811b36965
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77c8848526a96df2de46130a1b6f25a3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bde2c0a7b3e227e24ac242572e5f8010
date 2008-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2431123
https://doi.org/10.1016/s0140-6736%2808%2960727-8
https://pubmed.ncbi.nlm.nih.gov/18486741
isPartOf https://portal.issn.org/resource/ISSN/0140-6736
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D010997Q000188
http://id.nlm.nih.gov/mesh/D008654Q000188
http://id.nlm.nih.gov/mesh/D011788
http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D010997Q000473
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D012720
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D008654Q000473
http://id.nlm.nih.gov/mesh/D008654Q000145
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D010997Q000145
http://id.nlm.nih.gov/mesh/D011795
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3823887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73265388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11104792
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46931011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133126830
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129009934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296871
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311497
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13200033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44417235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6710780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44424639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5672

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128227540

Total number of triples: 79.